Harrow (HROW) Interest & Investment Income (2010 - 2014)
Harrow's (HROW) quarterly Interest & Investment Income came in at $5955.0 in Q4 2014, down 47.33% year-on-year from $11307.0 in Q4 2013, and down 20.62% quarter-over-quarter from $7502.0 in Q3 2014.
Harrow (HROW) Interest & Investment Income (2010 - 2014) Analysis & Trends
Harrow's Interest & Investment Income history runs 4 years deep, the most recent figure standing at $5955.0 for Q4 2014.
- On a quarterly basis, Interest & Investment Income fell 47.33% year-over-year to $5955.0 in Q4 2014; TTM through Dec 2014 was $32446.0, a 25.85% decrease from a year earlier, with the FY2014 full-year figure at $32446.0, down 25.85% from the prior year.
- Interest & Investment Income eased to $5955.0 in Q4 2014 per HROW's latest filing, from $7502.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $12940.0 in Q2 2013 and bottomed at $29.0 in Q4 2010.
- The 4-year median for Interest & Investment Income is $6511.5 (2013), against an average of $6570.7.
- Across the five-year window, Interest & Investment Income soared 194.72% in 2013 and sank 47.33% in 2014, its largest moves.
- Year by year, Interest & Investment Income stood at $29.0 in 2010, then soared by 19227.59% to $5605.0 in 2012, then soared by 101.73% to $11307.0 in 2013, then sank by 47.33% to $5955.0 in 2014.
- Per Business Quant, the three latest HROW Interest & Investment Income figures stand at $5955.0 (Q4 2014), $7502.0 (Q3 2014), and $8680.0 (Q2 2014).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 32.85 Mn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 41.80 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 28.10 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Harrow | 1.41 Bn | 1.32 Bn | 27.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 5,955.00 |
| Sep 30, 2014 | 7,502.00 |
| Jun 30, 2014 | 8,680.00 |
| Mar 31, 2014 | 10,309.00 |
| Dec 31, 2013 | 11,307.00 |
| Sep 30, 2013 | 12,440.00 |
| Jun 30, 2013 | 12,940.00 |
| Mar 31, 2013 | 7,068.00 |
| Dec 31, 2012 | 5,605.00 |
| Sep 30, 2012 | 4,221.00 |
| Jun 30, 2012 | 5,584.00 |
| Dec 31, 2010 | 29.00 |
| Sep 30, 2010 | 215.00 |
| Jun 30, 2010 | 135.00 |